Member Info for bobbust

they are working on recruitment and an RNS will come sometime.
The SP has fallen because people are selling. the volumes are small and could be any one of several reasons.
this could include they need the money or they bought excepting news which has not arrived.

the question is will news come in the near future. if you think yes buy if no hold or sell. its not that difficult.
I will keep buying

definitely a bit strange this week.
its not allowing a firm price on £500 buy or sell on ii
and she was even less impressed when I tried to get a quote for a £5000 sell.
All the movements down seam a bit much for the volumes unless of course the big buys were sells.
any way on to next week

At the AGM she said it was about 6m delay on the original plan due to the complexity of what they are doing.
My guess is deal Q1 2020.
But I do wonder if the Avidmab TCR deal will come 1st. Based on the poster from the last RNS

Don't forget
Link with Leukaemia research institute and
Avidmab Car-t /TCR link

as long as its not cooking dog

FG2811 a new ultra-specific antibody with the ability to induce human stem memory T cell (TSCM) proliferation and differentiation. TSCM cells are a rare subset of white blood cells with the stem cell–like ability to self-renew and have capacity to differentiate into other T cell subsets that proliferate and accelerate anti-tumour immunity. Therefore, FG2811 has the potential to be utilised in vivo for cancer immunotherapy or to provide cells for CAR-T or TCR adoptive cell therapies.

Progress is being made on TCR.
and with Biontech ready to pay for TCRs this is confirmation of progress which will translate into a deal.

Will defiantly be buying more

Not sure if today's RNS will have an effect on the sp but it's gold dust!!!!

trial
New patients only.
Long term 25-30% will show a positive reaction to CI
We will inject with both from the start.
If 55% show a positive reaction trial is a success.
People need to be quite ill when the turn up so recruitment not that easy

in the USA

Only one partner for AVIDmap, they just don't want there name out there.

the CI payment by the NHS for a trail is something SA got agreed.
We were only going to have one UK centre and 4 USA. so we have to get more agreements to pay for the CI
After FDA/ ichor problems we have moved to 3 uk and 2 USA

this really is ground breaking stuff. its going to take time
The board are really confident and are looking for a significant change in the SP in the next 6m to a year.
I spoke individually to RG, LD, SA and CH and on the way out Matthew Frohn.
All very positive, what was said and body language.
RG, SA and LD expressed frustration at the delays but that is due to the complexity of what they are doing.
RG did comment that some company's take an easier route but the rewards will be less.
LD is convinced we will save lives and make lots of money, and that's good enough for me.
Will continue buying

Chemo thing is only one of about 6 different ways it can be used
lots of opportunity for deals

enough cash to Q1 2021
Couple of inflection points due in the next year, SCIB1 data, Modi 1 start, Biontech TCR, New partner on AVIDmab
Avidmab acquired at very low cost, Uni not able to pay for patents so we took over, low cost payments after it takes off.
Avidmab very powerfull, should be able to target cancer cells with chemo drug attached which could lower toxicity of chemo.
patient recruitment for SCIB1 slow due to nature of how often very sick people come to the hospital.
Looking for two further centers in UK to speed this up but health service needs to agree to pay for Check point inhibiter.
Martian Diggle seams to know what he is talking about

At least we only have to wait a week to ask

Hi
Just thought I would remind people that is what Scancell is

Its ground breaking technology.

if at present the market does not see the value that is not the fault of the board.

be realistic and buy more because when the market does see the value you don't want to be in the pub telling your mates that you did not buy shares at 7p when they are £1 plus

Dis the board at your pearl.
They are always up to something to improve the IP

And it says a patent last 20 years and it normally takes 8 years to get to market.
If sclp were bigger it might have got to market quicker by a year but its small and you have a bigger share because of that

and a 2nd 75,000 at 7.5p

where did that come from

If you went and listened to them you would see how much is going on.
SP will follow IP.

As well as the pipe line/IP
He is not going to take over.
He has his own company to run and we are only one of many investments he has.